| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/18/2010 | US20100291090 Prion Protein as a Receptor for Amyloid-Beta Oligomers |
| 11/18/2010 | US20100291089 Ligand of regulating immune response, and use thereof in treating an immune response-related disease |
| 11/18/2010 | US20100291088 Il-18 binding proteins |
| 11/18/2010 | US20100291087 Method of treating fibrproliferative disorders |
| 11/18/2010 | US20100291086 Use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers |
| 11/18/2010 | US20100291085 Antibodies to ox-2/cd200 and uses thereof in inhibiting immune responses |
| 11/18/2010 | US20100291080 Compositions and methods for tissue repair |
| 11/18/2010 | US20100291079 Heterodimeric Follicle Stimulating Hormone-Fc (FSH-Fc) Fusion Proteins for the Treatment of Infertility |
| 11/18/2010 | US20100291074 Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's disease |
| 11/18/2010 | US20100291069 Methods of treating a diabetic embryopathy |
| 11/18/2010 | US20100291065 Compositions for Protein Delivery and Methods of Use Thereof |
| 11/18/2010 | US20100291064 Compounds and Methods for the Treatment of Vascular Disease |
| 11/18/2010 | US20100291063 Protease inhibition |
| 11/18/2010 | US20100291062 Antimicrobial Composition |
| 11/18/2010 | US20100291061 Process for making oligopeptides |
| 11/18/2010 | US20100291060 Subcutaneous administration of alpha-galactosidase a |
| 11/18/2010 | US20100291059 Pharmaceutical composition for enzyme replacement therapy |
| 11/18/2010 | US20100291058 Sealants for Skin and Other Tissues |
| 11/18/2010 | US20100291057 Composition for Reducing Oxidative Stress and/or Side Effects Occurring During Cancer Chemotherapy or Improving Nutritional Status During Cancer Chemotherapy |
| 11/18/2010 | US20100291056 Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same |
| 11/18/2010 | US20100291055 Surgical hydrogel |
| 11/18/2010 | US20100291044 Lunasin-induced regulation of disease-related gene expression |
| 11/18/2010 | US20100291036 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression |
| 11/18/2010 | US20100291035 Respiratory syncytial virus with a genomic deficiency complemented in trans |
| 11/18/2010 | US20100291034 Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related thereto |
| 11/18/2010 | US20100291033 Albumin Fusion Proteins |
| 11/18/2010 | US20100291032 Compositions and methods for the identification of inhibitors of retroviral infection |
| 11/18/2010 | US20100291031 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 11/18/2010 | US20100291030 Use of il-28 and il-29 to treat cancer and autoimmune disorders |
| 11/18/2010 | US20100291029 Methods of using il-21 |
| 11/18/2010 | US20100291028 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases |
| 11/18/2010 | US20100291027 Hyaluronic acid (ha) injection vehicle |
| 11/18/2010 | US20100291026 Piperidine inhibitors of janus kinase 3 |
| 11/18/2010 | US20100291025 Indazole inhibitors of tyrosine kinase |
| 11/18/2010 | US20100291024 Methods and compositions for the treatment of proliferative and pathogenic diseases |
| 11/18/2010 | US20100291023 Method for extending the half-life of exogenous or endogenous soluble molecules |
| 11/18/2010 | US20100291007 Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase |
| 11/18/2010 | US20100290994 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 11/18/2010 | US20100290989 Compositions affecting hyaluronic acid mediated activity |
| 11/18/2010 | US20100290987 Methods and compositions for detecting and modulating o-glycosylation |
| 11/18/2010 | US20100290983 Compositions and Methods for Drug Delivery |
| 11/18/2010 | CA2763359A1 New human rotavirus strains and vaccines |
| 11/18/2010 | CA2761901A1 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| 11/18/2010 | CA2761896A1 Cyclin dependent kinase inhibitors and methods of use |
| 11/18/2010 | CA2761674A1 Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds |
| 11/18/2010 | CA2761480A1 Lactoferrin and brain health and development in infants |
| 11/18/2010 | CA2761457A1 Immortalized avian cell lines and use thereof |
| 11/18/2010 | CA2761438A1 Compositions and methods for treating hematologic cancers targeting the sirp-.alpha.-cd47 interaction |
| 11/18/2010 | CA2761437A1 Lactoferrin and neuronal health and development in the infant gut |
| 11/18/2010 | CA2761393A1 Ttk peptides and vaccines including the same |
| 11/18/2010 | CA2760519A1 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 11/18/2010 | CA2760465A1 Method for orthopoxvirus production and purification |
| 11/17/2010 | EP2251434A1 Compositions and methods for siRNA inhibition of ICAM-1 |
| 11/17/2010 | EP2251426A1 Mammalian-type glycosylation in plants |
| 11/17/2010 | EP2251424A1 Antigenic neisserial peptides |
| 11/17/2010 | EP2251353A1 Homogeneous preparations of IL-28 and IL-29 |
| 11/17/2010 | EP2251352A1 Homogeneous preparations of IL-28 and IL-29 |
| 11/17/2010 | EP2251351A1 Sclerostin epitopes |
| 11/17/2010 | EP2251348A2 Peptides and their use |
| 11/17/2010 | EP2251344A1 Formulation of boronic acid compounds |
| 11/17/2010 | EP2251040A1 Use of a melanoma differentiation associated gene (mda 7) for reversing a cancerous phenotype |
| 11/17/2010 | EP2251033A1 Pharmaceutical formulations comprising paraoxonase |
| 11/17/2010 | EP2251032A1 Lactoferrin and brain health and protection in adults |
| 11/17/2010 | EP2251031A1 Lactoferrin and neuronal health and development in the infant gut |
| 11/17/2010 | EP2251030A1 Lactoferrin and brain health and development in infants |
| 11/17/2010 | EP2251029A1 Lactoferrin and gut neuronal health in adults and/or elderly |
| 11/17/2010 | EP2251028A1 Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor |
| 11/17/2010 | EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury |
| 11/17/2010 | EP2251025A1 Use of inclusion bodies as therapeutic agents |
| 11/17/2010 | EP2251008A1 Methods for reducing the effects of stress on skin condition |
| 11/17/2010 | EP2251007A2 Sphingosine-1-phosphate (S1P) receptor agonists for use in the treatment of demyelinating diseases |
| 11/17/2010 | EP2251006A1 Microparticles and pharmaceutical compositions thereof |
| 11/17/2010 | EP2250201A1 Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 11/17/2010 | EP2250192A1 Protein or glycoprotein from haliotis midae and its use as an immunotherapy agent |
| 11/17/2010 | EP2250189A1 Glycopeptides and methods of making and using them |
| 11/17/2010 | EP2250187A2 Novel peptide and cosmetic and/or pharmaceutical composition containing same |
| 11/17/2010 | EP2250185A1 Novel lupane derivatives |
| 11/17/2010 | EP2249879A2 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix |
| 11/17/2010 | EP2249869A1 Liquid formulation of fsh |
| 11/17/2010 | EP2249868A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 11/17/2010 | EP2249863A1 Method of improving wound healing |
| 11/17/2010 | EP2249862A1 Clottable concentrate of platelet growth factors and preparation method thereof |
| 11/17/2010 | EP2249861A1 Treating neurodegenerative diseases with progranulin (pgrn) |
| 11/17/2010 | EP2249860A2 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 11/17/2010 | EP2249859A1 Treatment of metastatic stage prostate cancer with degarelix |
| 11/17/2010 | EP2249858A1 Method of treating prostate cancer with the gnrh antagonist degarelix |
| 11/17/2010 | EP2249857A2 Malaria vaccine compositions and constituents which elicit cell mediated immunity |
| 11/17/2010 | EP2249856A2 Peptides that target dorsal root ganglion neurons |
| 11/17/2010 | EP2249855A1 Immunogenic peptides and their use in transplantation |
| 11/17/2010 | EP2249854A1 Improved treatment and prophylaxis |
| 11/17/2010 | EP2249853A1 Ester-based peptide prodrugs |
| 11/17/2010 | EP2249837A1 Methods of treating thromboembolic disorders |
| 11/17/2010 | EP2249809A1 Powdered protein compositions and methods of making same |
| 11/17/2010 | EP2249794A2 Compositions and methods comprising basic amino acid peptides and proteases |
| 11/17/2010 | EP1830872B1 Fusion proteins |
| 11/17/2010 | EP1760153B1 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells |
| 11/17/2010 | EP1576182B1 Product quality enhancement in mammalian cell culture processes for protein production |
| 11/17/2010 | EP1565489B1 Internalizing antibodies specific for the RAAG10 cell surface target |
| 11/17/2010 | EP1506295B1 Muteins of placental growth factor type 1, preparation method and application thereof |
| 11/17/2010 | EP1499719B1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS |